Retained EU Law 2020 United Kingdom

Regulation (EU) 2020/1043 of the European Parliament and of the Council of 15 July 2020 on the conduct of clinical trials with and supply of medicinal products for human use containing or consisting of genetically modified organisms intended to treat or prevent coronavirus disease (COVID-19) (Text with EEA relevance)

At a glance

What's here

1 compliance obligation

What this Act requires

Sections that create concrete duties on businesses or carry penalties. Procedural and definitional sections are folded into the “Browse other sections” expander at the bottom of each group. Click any section title to read the source text on legislation.gov.uk.

s.art002

(1) All operations related to the conduct of clinical trials,...

  • Sponsors must minimise environmental risks from GMO clinical trials
Browse 4 other sections — procedural / definitional / commencement
s.art001

For the purposes of this Regulation, the following definitions apply:...

s.art003

(1) Articles 6 to 11 and 13 to 24 of...

s.art004

(1) This Regulation shall apply as long as WHO has...

s.art005

This Regulation shall enter into force on the day following...

Explore more

Browse legislation

Find other UK business legislation with related guidance.